Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysisKamar Godder, Mary Eapen, Joseph H Laver, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamideChristopher N Bredeson, Mei-Jie Zhang, Manza-A Agovi, et al.
Blood|January 21, 2021
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trialEphraim J Fuchs, Paul V O'Donnell, Mary Eapen, et al.
The Lancet. Oncology|June 19, 2010
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisMary Eapen, Vanderson Rocha, Guillermo Sanz, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Blood|July 2, 2014
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCTCorey Cutler, Brent Logan, Ryotaro Nakamura, et al.
The Lancet. Oncology|October 11, 2011
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysisMary Eapen, John P Klein, Guillermo F Sanz, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Cancer|August 10, 2021
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementationErica D Warlick, Celalettin Ustun, Astrid Andreescu, et al.
Blood|October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M Pagel, Frederick R Appelbaum, Janet F Eary, et al.
Pageof 29